Publication | Closed Access

Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor

ThrombosisOxysterolChemoprevention StrategyBiochemistryMedicineLipid PeroxidationPreclinical Safety EvaluationVascular BiologyPharmacotherapyCardiovascular ToxicityPharmacologyAtherosclerosisOxidative Stress